ProPhase Labs, Inc.
PRPH
$0.3326
$0.00130.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.85M | 6.77M | 2.08M | 7.29M | 18.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.85M | 6.77M | 2.08M | 7.29M | 18.04M |
| Cost of Revenue | 5.41M | 6.92M | 6.52M | 9.24M | 13.06M |
| Gross Profit | 436.00K | -150.00K | -4.44M | -1.95M | 4.98M |
| SG&A Expenses | 34.68M | 37.89M | 29.12M | 29.72M | 32.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.51M | 45.40M | 36.43M | 40.19M | 47.76M |
| Operating Income | -34.66M | -38.63M | -34.35M | -32.90M | -29.73M |
| Income Before Tax | -38.92M | -42.33M | -36.89M | -34.58M | -31.05M |
| Income Tax Expenses | 9.76M | 7.20M | -10.28M | -9.41M | -8.60M |
| Earnings from Continuing Operations | -48.68 | -49.53 | -26.61 | -25.17 | -22.45 |
| Earnings from Discontinued Operations | 5.55M | -3.84M | -741.00K | -741.00K | -741.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.13M | -53.36M | -27.76M | -26.31M | -23.60M |
| EBIT | -34.66M | -38.63M | -34.35M | -32.90M | -29.73M |
| EBITDA | -28.60M | -32.44M | -27.13M | -26.26M | -23.36M |
| EPS Basic | -2.15 | -2.61 | -1.52 | -1.47 | -1.35 |
| Normalized Basic EPS | -1.08 | -1.28 | -1.26 | -1.21 | -1.11 |
| EPS Diluted | -2.15 | -2.61 | -1.53 | -1.48 | -1.35 |
| Normalized Diluted EPS | -1.08 | -1.28 | -1.26 | -1.21 | -1.11 |
| Average Basic Shares Outstanding | 93.66M | 76.48M | 73.22M | 71.32M | 69.27M |
| Average Diluted Shares Outstanding | 93.66M | 76.48M | 73.22M | 71.32M | 69.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |